KAYNAKLAR:
1- Butchko HH, Stargel WW, Comer CP, Mayhew DA, Benninger C, Blackburn GL, et al. Aspartame: Review of safety. Regul Toxicol Pharmacol 35(2 Pt 2): S1-93; 2002.
2- Butchko HH, Stargel WW. Aspartame: Scientific evaluation in the postmarketing period. Regul Toxicol Pharmacol 34(3): 221-33; 2001.
3- Budavari S, O'Neil MJ, Smith A. The Merck Index. 11th edition. U.S.A.: Merck&Co, Inc. 1989; 132.
4- Conning DM. Toxicology of food and food additives. In: Ballantyne B, Mars TC, Syversen T, eds. General and Applied Toxicology. 2th ed. Vol 3. New York: Grove's dictinaries Inc. 1999; 1977-92.
5- Potenza DP, El-Mallakh RE. Aspartame: Clinical update. Conn Med 53(7): 395-400; 1989.
6- Kleinjans JCS. Food toxicity: the toxicological history of aspartame. In: Niesink RJM, Vries J, Hollinger MA, eds. Toxicology Principles and Applications. New York: CRC Press, Inc. 1996; 1055-80.
7- Homler BE. Properties and stability of aspartame. Food technology 38: 50-5; 1984.
8- Baydar T, Şahin G. Aspartam metabolizması ve toksisitesi. T Klin J Med Sci 17(3):141-52; 1997.
9- (link) Assesment report: Opinion on a possiblelink between exposition to aspartame and the incidence of brain tumors in humans. Report in French. AFSSA 2002.
10- Briggs GG, Freeman RK, Yaffe SJ. Fetal ve Neonatal Risk Yönünden Referans Rehberi. Gebelikte ve Laktasyon Döneminde İlaç Kullanımı (Drugs in Pregnancy and Lactation). 5th ed. Çeviri: Dr. Barış Örnek Bügü. İstanbul: Nobel Tıp Kitapevleri. 2001; 68-73.
11- Lipton WE, Li Y, Younoszai MK, Stegink LD. İntestinal absorption of aspartame decomposition products in adult rats. Metabolism 40(12): 1337-45; 1991.
12- Türk Gıda Kodeksi Yönetmeliği. Resmi Gazete. S:23/72; 2,6,7,9,41,46, 47; 16 Kasım 1997.
13- Quinlan M, Mialon V, Everitt M. Effect of storage on the flavours of cola drinks sweetened with different sweetener system. World Rev Nutr Diet 85: 58-63; 1999.
14- Neopterins in clinical medicine. Lancet 5;1 (8584); 509-11; 1988.
15- Janssen PJCM, Heijden CA. Aspartame: Review of recent experimental and observational data. Toxicology 50: 1-26; 1988.
16- Harper AE. Phenylalanine metabolism. In: Stegink LD, Filer LJ, eds. Aspartame-Physiology and Biochemistry. New York: Marcel Dekker Inc. 1984; 77-109.
17- Kaufman S. Differential diagnosis of variant forms of hyperphenylalaninemia. Pediatrics. 65(4):840-1; 1980.
18- La Buda CJ, Hale RL. Anxiety in mice following acute aspartame and ethanol exposure. Alcohol. 20(1):69-74; 2000.
19- Stegink LD, Brummel MC, Mc Martin K, Martin-Amat G, Filer LJ, Baker GL, et all. Blood methanol concentrations in normal adult subjects administered abuse doses of aspartame. J Toxicol Environ Health 7: 281-90; 1981.
20- Nguyen UN, Dumoulin G, Henriet M, Regnard J. Aspartame ingestion increases urinary calcium, but not oxalate excretion, in healthy subjects. J Clin Endocrinol Metab 83(1): 165-8; 1998.
21- Leon AS. Comment on effect of large doses of aspartame on urinary calcium excretion. J Clin Endocrinol Metab 84(1): 383-4; 1999.
22- Pitkin RM. Aspartame ingestion during pregnancy. In: Stegink LD, Filer LJ, eds. Aspartame physiology and biochemistry. New York: Marcel Dekker Inc. 1984; 555-64.
23- Koeppe RA, Shulkin BL, Rosenspire KC, Shaw LA, Betz AL, Mangner T, et all. Effects of aspartame-derived phenylalanine on neutral amino acid uptake in human brain: A positron emission tomography study. J Neurochemistry 56(5): 1526-35; 1991.
24- Beck B, Burlet A, Max JP, Stricker-Krongrad A. Effects of long-term ingestion of aspartame on hypothalamic neuropeptide Y, plasma leptin and body weight gain and composition. Physiol Behav 1-15; 75(1-2): 41-7; 2002.
25- Spiers PA, Sabounjian L, Reiner A, Myers DK, Wurtman J, Schomer DL. Aspartame: neuropsychologic and neurophysiologic evaluation of acute and chronic effects. Am J Clin Nutr 68(3): 531-7; 1998.
26- Goerss AL, Wagner GC, Hill WL. Acute effects of aspartame on aggression and neurochemistry of rats. Life Sci 67(11): 1325-9; 2000.
27- Millichap JG, Yee MM. The diet factor in pediatric and adolescent migraine. Pediatr Neurol 28(1): 9-15; 2003.
28- Schwartz GR. Aspartame and breast and other cancers. West J Med 171(5-6): 300-1; 1999.
29- Trocho C, Pardo R, Rafecas I, Virgili J, Ramesar X, Fernandez-Lopez JA, et all. Formaldehyde derived from dietary aspartame binds to tissue components in vivo. Life Sci 63(5): 337-49; 1998.
30- Tephly TR. Comments on the purported generation of formaldehyde and adduct formation from the sweetener aspartame. Life Sci 65(13): 157-60; 1999.
31- Oyama Y, Sakai H, Arata T, Okano Y, Akaike N, Sakai K, et all. Cytotoxic effects of metanol,
formaldehyde, and formate on dissociated rat thymocytes: A possibility of aspartame toxicity. Cell Biol Toxicol 18(1): 43-50; 2002.
32- Karikas GA, Schulpis KH, Reclos G, Kokotos G. Measurement of molecular interaction of aspartame and its metabolites with DNA. Clin Biochem 31(5): 405-7; 1998.
33- Jeffrey AM, Williama GM. Lack of DNA-damaging activity of five non-nutritive sweeteners in rat hepatocyte/DNA repair assay. Food Chem Toxicol 38(4): 335-8; 2000.
34- Belogolovskaya EG, Oreshchenko AV, Durnev AD, Seredenin SB, Litvinova EV, Zubtsov YN. Effects of beta-carotene and aspartame on clustogenic activity of cyclophosphamide and dioxidine in mice. Bull Exp Biol Med 130(11):1102-5; 2000.
35- Mukhopadhyay M, Mukherjee A, Chakrabarti J. In vivo cytogenetic studies on blends of aspartame and acesulfame-K. Food Chem Toxicol 38(1): 75-7; 2000.
36- Leclercq C, Berardi D, Sorbillo MR, Lambe J. Intake of saccarin, aspartame, acesulfam-K and cyclamate in Italian teenagers: present levels and projections. Food Addit Contam 16(3): 99-109; 1999.
37- Verger P, Garnier-Sagne I, Leblanc JC. Identification of risk groups for intake of food chemicals. Regul Toxicol Pharmacol 30: 103-8; 1999.
38- Garnier-Sagne I, Leblanc JC, Verger P. Calculation of the intake of three intense sweeteners in young insulin-dependent diabetics. Food Chem Toxicol 39(7): 745-7; 2001.
39- Puthrasingam S, Heybroek WM, Johnston A, Maskrey V, Swift CG, Turner P, et all. Aspartame pharmacokinetics-the effect of ageing. Age Ageing 25(3): 217-20; 1996.
40- da Silva LC, Carvalho TS, da Silva FB, Pires RF, Giugliani R, Pereira ML. Aspartame loading test in PKU heterozygous individuals bearing severe and moderate mutations. Clin Genet 58(1): 86-88; 2000.
41- Stegink LD, Filer LJ, Bell EF, Ziegler EE, Tephly TR, Krause WL. Repeated ingestion of aspartame-sweetened beverages: Further observation in individuals heterozygous for phenyketonuria. Metabolism 39(10): 1076-81; 1990.
42- Filer LJ, Stegink LD. Aspartame metabolism in normal adults, phenlketonuric heterozygotes, and diabetic subjects. Diabetes Care 12(1): 67-74; 1989.
43- Malaisse WJ, Vanonderbergen A, Louchami K, Jijakli H, Malaisse-Lagae F. Effects of artificaial sweeteners on insulin release and cationic fluxes in rat pancreatic islets. Cell Signal 10(10): 727-33; 1998.
44- Prat-Larquemin L, Oppert JM, Bellisle F, Guy-Grand B. Sweet taste of aspartame and sucrose: effects on diet- induced thermogenesis. Appetite 34(3): 245-51; 2000.
45- Rowan AJ, Shaywitz BA, Tuchman L, French JA, Luciano D, Sullivan CM. Aspartame and seizure susceptibility: results of a clinical study in reportedly sensitive individuals. Epilepsia 36(3): 270-5; 1995.
46- (link) Opinion of the SCF: Update of safety of aspartame. European Commission; 2002.
47- Hertelendy ZI, Mendenhall CL, Rouster SD, Marshall L, Weesner R. Biochemical and clinical effects of aspartame in patients with chronic, stable alcoholic liver disease. Am J Gastroenterology 88(5): 737-43; 1993.
bunlar benim verdiğim linkin kaynakları..Sizin linkinizin kaynakları nerede?Falanca üniversitede yapılan bir araştırmanın sonuçları yazılmıs.Ben arastırmayı incelemek istersem nereden bilgi edinmem gerekiyor..???Bu arastırma hangi sartlarda hangi populasyonlarda ne kadar süre ile denenmiş.Bunların yanıtları nerede..? Demek ki arada bir fark var....Haber ve literatür arasındaki fark budur.Yoksa olay şeker fabrikası ya da üniversite meselesi degil...!!!